Factor V Leiden and prothrombin G20210A mutations and risk of vaso-occlusive complications in sickle cell disease: A meta-analysis through the lens of nephrology

Lakkakula VKS Bhaskar *

Cited by CrossRef: 2

1- Lakkakula B, Pattnaik S. The HBG2 rs7482144 (C > T) Polymorphism is Linked to HbF Levels but not to the Severity of Sickle Cell Anemia. J Pediatr Genet. 2023;12(02):129 [Crossref]

2- Ahmed A, Eltayeb R, Alsaif G, Siddeeg S, Nasreldeen R, Elhag D, Alimam S, Abdalla E. Screening of Factor V Leiden mutation and activated protein C resistance in Sudanese children with sickle cell disease and stroke: A descriptive cross-sectional study. 2025;104(43):e45433 [Crossref]

3- Verma H, Ratre Y, Bhaskar L, Colombatti R. Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy. Ann Hematol. 2021;100(3):607 [Crossref]